Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-05-13
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514285, 514410, 514866, 514884, A61K 3144, A61K 3140
Patent
active
056293194
ABSTRACT:
The use of extracts from Cryptolepis sp. or quindoline alkaloids such quindoline and cryptolepine contained therein as hypoglycemic agents, as well as methods for obtaining the hypoglycemic agents are described. According to a preferred embodiment, the extracts are derived from Cryptolepis sanguinolenta. As hypoglycemic agents, the extracts or quindoline alkaloids such as quindoline or cryptolepine are useful for treating insulin-dependent (type I) and non-insulin-dependent (type II) diabetes.
REFERENCES:
patent: 3374264 (1968-03-01), Uskokovic et al.
patent: 4826850 (1989-05-01), Yamato
Baldwin and Magnus (eds.), 1994, in Organic Syntheses Based on Name Reactions and Unnamed Reactions, vol. 11, p. 36.
Blount et al., 1929, "Steroisomerism in polycyclic systems. Part VI", J Chem Soc pp. 1975-1987.
Chang et al., 1992, "Synthesis of 7-substituted indolo[3,2-b]-quinoline derivatives", Heterocycles 33(1):147-152.
Degutis and Ezyarskaite, 1986, "Alkylation of quindoline and quindoline-11-carboxylic acid", Khimiya Geterotsiklicheskikh Soedinenii 10:1375-1379.
Desarbre and Merour, 1994, "Synthesis and reactivity of 1-substituted-3H-pyrrolo[2,3-b] pyridin-3-one", Tetrahedrom Letters 35(13):1995-1998.
Ezyarskaite, 1989, "One the synthesis of 7-bromoquindoline derivatives", Izv Khim 22:101-105.
Galun et al., 1979, "Derivatives of indole-3-pxyacetic acid", J Heterocyclic Chem 16:641-643.
Giraud, 1879, "Sur quelques d eriv es de l'indigotine", Comptes Rendus pp. 104-105.
Giraud, 1880, "Pr eparation de l'indoline et de ses compos es", Comptes Rendus pp. 1429-1430.
G orlitzer and Weber, 1980, "11-oxo-5,11-dihydro-benzothieno[3,2-b][1] chinoline, S,S-dioxide und thionierungsprodukte", Arch Pharm 314:76-84.
G orlitzer and Weber, 1982, "hemmung der thrombocytenaggregation durch anellierte chinoline mit 3-dimethylaminopropylmercapto-substituenten", Arch Phar 315:532-537.
G orlitzer and Weber, 1981, "10-hydroxy-10H-indolo[3,2-b]chinolin-5-oxid (`Dioxychindolin`)", Arch Pharm 314:850-852.
G orlitzer and Weber, 1980, "Anellierte chinoline III), 11-oxo-5,11-dihydro-benzothieno-[3,2-b][1] chinoline", Arch Pharm 313:27-34.
G orlitzer et al., 1994, "Anti-malaria active 10H-indolo[3,2-b]quinolin-11-ylamines. Part I. Phenol-Mannich-bases of the amodiaquine and cycloquine type", Pharmazie 49:231-235.
G orlitzer, 1976, "Untersuchungen an 1,3-dicarbonylverbindungen, 6. Mitt. Anerllierte chinolone", Arch Pharm 309:18-25.
G orlitzer and Weber, 1981, "10H-indolo[3,2-b]chinolin", Arch Pharm 314:852-861.
G orlitzer et al., 1995, "gegen malaria wirksame 10H-indolo[3,2-b]chinolin-11-yl-amine", Pharmazie 50:105-111.
G orlizter, 1979, "Anellierte chinolone II, N- und O-alkylierungsprodukte", Arch Pharm 312:254-261.
Holt and Petrow, 1948, "Carbazoles, carbolines, and related compounds. Part III. Quinindoline derivatives", pp. 922-924.
Holt and Petrow, 1947, "Carbazoles, carbolines, and related compounds. Part I. Quindoline derivatives", pp. 607-611.
Holt and Petrow, 1948, "Carbazoles, carbolines, and related compounds. Part II. Transformations of some quarternary salts of quindoline", pp. 919-922.
Jezerskaite et al., 1989, "New heterocylic sensitizers for electrophotography", Izv Khim 22:113-121.
Kempter et al., 1963, Z Chem 3:352-353.
Merour et al., 1982, "Syntheses of 2(5)-substituted 1-acetyl-3-oxo-2,3-dihydroindoles, 3-acetoxy-1-acetylindoles, and of 2-methyl-5-methoxyindole-3-acetic acid", Synthesis 12:1053-1056.
Mooradian et al., 1949, "A new series of testosterone esters", J Amer Chem Soc 71:3372-3374.
Nenitzescu and Raileaniu, 1958, "Synthesen des heteroauxins, des tryptamins und des serotonins", Chem Ber 91:1141-1145.
Ossman et al., 1988, "Synthesis of 2-cyanomethyl-3, 1-benzoxazin-4(H)-one", Egypt J Chem 31(3):381-385.
Schoen and Bogdanowicz-Szwed, 1964, "The reaction of .alpha.-indanone anils with phenylisocyanate. Anilides of 1-arylamino-indene-2-carboxylic acids", Roczniki Chemi Ann Soc Chim Polonorum 38:425-435.
Schulte et al., 1972, "Kondensierte indole aus 2-chlorindoaldehyd-(3)", Arch Pharmaz 305:523-533.
Schutzenberger, 1877, "Note sur un nouveau d eriv de l'indigotine", Comptes Rendus pp. 147-149.
Sevodine et al., 1982, "New methods for the synthesis of quindolines on the basis of 1,5-diketones of the indolinone series", Chem Heterocyclic Compounds 18(8):865.
Sevodin et al., 1984, "New method of synthesis of quindolines from 1,5-diketones of the indoline series", Chem Heterocylic Comp 20(12):1374-1380.
Sunder and Peet, 1978, "Synthesis of benzofuro[3,2-b] quinolin-6(11H)one and derivatives", J Heterocyclic Chem 15:1379-1382.
Takeuchi et al., 1991, "Synthesis and antitumor activity of 7-(N-glycosylamino)-indolo[3,2-b]quinolines", Chem Pharm Bull 39(6):1629-1631.
Takeuchi et al., 1992, "Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines", Chem Pharm Bull 40(6): 1481-1485.
Yamato et al., 1989, "Synthesis and antitumor activity of fused tetracyclic quinoline derivatives", J Med Chem 32:1295-1300.
Yamato et al., 1992, "Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4-and 7-hydroxyindolo[3,2-b]quinolines", Chem Pharm Bull 40(2):528-530.
Yamato et al., 1990, "Synthesis and antitumor activity of fused quinoline derivatives", Chem Pharm Bull 38(11):3048-3052.
Paulo et al., 1994, "In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids", J Ethnopharmacol 44:127-130.
Oyekan and Ablordeppey, 1993, "The mechanism(s) of the antiaggregatory effects of cryptolepine: The role of cyclic adenosine monophosphate and cellular ca.sup.2+ ", Gen Pharmacol 24(2):461-469.
Proceedings from the 1st International seminar on cryptolepine, University of Science and Technology Kumasi, Jul. 27-30 1983, Boakye-Yiadom & Bamgbose (eds.), pp. 1-82.
Spitzer et al., 1991, "Total Assignment of the proton and carbon NMR spectra of the alkaloid quindoline - Utilization of HMQC-TOCSY to indirectly establish protonated carbon-protonated carbon connectivities", J Heterocyclic Chem 28:2065-2070.
Wilson et al., 1922, "Polynuclar Heterocyclic aromatic types. Part I. Some indenoquinoline derivateves", J Chem Soc pp. 827-839.
Fichter and Rohner, 1910, " Uber einige derivate des chindolins", Chem. Ber. 43:3489-3499.
Fichter and Probst, 1907, "Zur kenntnis des methyl-hindolanols", Chem. Ber. 40:3478.
Okeyan, 1994, Role of the Endothelium and Cyclic GMP in Renal Vasodilator Responses to Cryptolepine in Rats, J. Cardiovasc. Pharmacol. 23:602-611.
Oyekan and Ablordeppey, 1993, Effects of Cryptolepine on Collagen-Induced Aggregation and on the Mobilization and Metabolism of Arachidonic Acid by Rabbit, Gen. Pharmac. 24:1285-1290.
Rauwald et al., 1992, Cryptolepis sanguinolenta:Antimuscarinc Properties of Cryptolepine and the Alkaloid Fraction at M1,M2 and M3 Receptors, Planta Medica, 58:486-488.
Cimanga et al., 1991, Biological Activities of Cryptolepine, An Alkaloid from Cryptolepis sanguinolenta, Planta Medica 57 Supp. 2 A98-A99.
Tackie et al., 1991, Assignment of the Proton and Carbon NMR Spectra of the Indoloquinoline Alkaloid Cryptolepine, J. Heterocycl. Chem. 28:1429-1435.
Ablordeppy et al., 1990, .sup.1 H-NMR and .sup.13 C-NMR Assignments of Cryptolepine A 3 : 4-Benz.delta.-carboline Derivative Isolated from Cryptolepis sanguinolenta,Planta Medica 56:416.
Oyekan and Okafor, 1989, Effects of Cryptolepine Alone and in Combination with Dipyridamole on a Mouse Model of Arterial Thrombosis, J. Ethnopharmacology 27:141-148.
Potential Antimalarial in Ghanian Plant, IMS Pharmaceutical Marketletter, May 7, 1984, pp. 13.
Cryptolepine Hydrochloride, Drugs Future, 1982, 7(7): 466.
Bamgbose and Noamesi, 1981, Studies on Cryptolepine, Planta Medica 41:392-396.
Noamesi et al., 1980, The Alpha-Adrenoceptor Blocking Properties of Cryptolepine on the Rat Isolated Vas Deferens, Planta Medica 39:51-56.
Gunatilaka et al., 1980, Studies on Medicinal Plants of Sri Lanka, Planta Medica, 39:66-72.
Boakye-Yiadom et al., 1979, Cryptolepine Hydrochloride Effect on Staphylococcus aureus, J. Pharm. Sci. 68:1510.-1514.
Dwuma-Badu et al., 1978, Constituents of West Afric
Bierer Donald E.
Bruening Reimar C.
Fort Diana M.
Luo Jian
Rollins John W.
Shaman Pharmaceuticals, Inc.
LandOfFree
Hypoglycemic agent from cryptolepis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycemic agent from cryptolepis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic agent from cryptolepis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385576